1.
Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina. Biomol Biomed [Internet]. 2024 Apr. 28 [cited 2024 Jul. 3];. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/10433